Acute tumor lysis syndrome after rituximab administration in Burkitt’s lymphoma

Acute tumor lysis syndrome after rituximab administration in Burkitt’s lymphoma

Saved in:
Bibliographic Details
Published in:Internal and emergency medicine Vol. 3; no. 2; pp. 161 - 163
Main Authors: Otrock, Zaher K., Hatoum, Hassan A., Salem, Ziad M.
Format: Journal Article
Language:English
Published: Milan Springer Milan 01-06-2008
Springer Nature B.V
Subjects:
Acute Disease
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents - adverse effects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Burkitt Lymphoma - drug therapy
Burkitt Lymphoma - physiopathology
CE - Letter to the Editor
Humans
Internal Medicine
Male
Medicine
Medicine & Public Health
Middle Aged
Risk Factors
Rituximab
Tumor Lysis Syndrome - drug therapy
Tumor Lysis Syndrome - etiology
Uric Acid
Chronic Lymphocytic Leukemia
Tumor Lysis Syndrome
Autoimmune Hemolytic Anemia
Bone Marrow Aspirate
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1828-0447
1970-9366
DOI:10.1007/s11739-008-0099-1